Avaliação e caracterização de bacteriófagos líticos e suas endolisinas recombinantes para controle de Staphylococcus aureus na cadeia produtiva do leite
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Bovine mastitis is an infection that affects dairy herds. This disease is often associated
with Staphylococcus aureus, resulting in economic losses for the milk production chain.
Furthermore, these bacteria can produce enterotoxins and cause food poisoning in
humans. The indiscriminate use of antibiotics to control pathogens in livestock and
humans carries with it risks, such as the selection of resistant bacteria, which can
reduce the effectiveness of these drugs. In addition, such practices have raised
concerns about food safety and environmental impact. Therefore, an increasing
number of scientific studies have been dedicated to investigating new therapeutic
options that can be used as alternatives to conventional treatment. A promising
alternative for biological control of S. aureus is the use of lytic bacteriophages and their
endolysins, which have the ability to lyse bacteria. Thus, the objective of this work was
to evaluate and characterize lytic bacteriophages and their recombinant endolysins
regarding their antimicrobial activity against S. aureus. The phages were submitted to
morphological and biochemical characterization, as well as tested against different
bacterial strains of S. aureus and other species. Furthermore, endolysins from Phage
2 and 4 were expressed, purified and evaluated for lytic spectrum. They were also
characterized in silico in relation to morphological, biochemical and allergenicity
aspects. By analyzing the morphology of Phages 2 and 4, it was possible to conclude
that both belong to the Siphoviridae family. Among the strains tested, Phage 2 lysed
62.22% of them, while Phage 4 lysed 51.11%. Phage 2 maintained its stability in a
temperature range between 4°C and 37°C, as well as in NaCl concentrations between
50 mM and 250 mM. Furthermore, in the present study, it was identified that the two
endolysins, EndF2 and EndF4, have a CHAP domain, an Amidase2 domain and an
SH3 cell wall binding domain, and both did not show critical aspects of allergenicity. It
was demonstrated that recombinant endolysins exhibit high lytic activity against
staphylococcal strains, in which EndF2 lysed 71.43% and EndF4 76.20% of the S.
aureus strains tested. It is concluded that Phages 2 and 4 and their respective
recombinant endolysins EndF2 and EndF4 proved to be active on S. aureus strains
and that they may constitute an alternative to control this pathogen. To prove the
results, in vivo tests are necessary.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

